Filtrai

Renginiai Sveikatos priežiūra, vaistinė Londonas, Didžioji Britanija 2023

4 events

Daugiau...
ADMET studies perform a vital role in the drug discovery process. Early stage In-Silico models can predict the viability of a new novel drug before anyone steps into a lab. The In-Vitro and In-Vivo models allow the testing of new molecules to discover how tell they cope in a physiological environment and save Pharma companies millions by stoping the development of drugs destined to fail. As more data is generated by the lab studies, more data becomes available for the computational scientists and so out predictive abilities improve. This conference will address the barriers that are currently faced by the PK/PD community and also how recent discoveries have improved the understanding of the mechanisms involved in ADME-Tox. It will also address the new technologies and techniques being developed to overcome the classic physiological barriers to drug bioavailability. Attendees will hear presentations from senior experts in the field on the current issues as well as case studies from recent drug development programmes.
The British Dental Trade Association looks forward to welcoming you to a record-breaking London Dental Showcase, which has oustripped all previous London shows with more exhibitors and stands than ever before. Those who have visited Showcase before know just what a superb opportunity it is to see the latest technologies, equipment and sundries all displayed conveniently under one roof. The BDTA has put together a show that is intended to be both educational and enjoyable and to provide a valuable resource for every member of the dental team.
Ladies and gentlemen! Visitors and exibitors! Welcome to the Charing Cross International Symposium!At the Charing Cross International Symposium the representatives from many specialties and disciplines within radiology, from different countries, will discuss recent scientific and clinical achievements and exchange clinical research ideas.
Pain affects all of us some of the time, and many of us all the time. Yet, the pharmacologic treatments available to alleviate pain have changed little in the last 50 years. Those who suffer from acute pain originating in the peripheral nervous system have the best chances of finding relief, while others suffering chronic neuropathic pain must often settle for partial or even minimal relief. In addition the current models and theories of pain and its mechanisms have failed to yeild significantly new therapeutics over recent years. Now in its 12th year, SMi's annual Pain Therapeutic conference series has gone from strength to strength; join our faculty of top-level speakers and address the current issues facing the clinical R&D field of pain drug development.